shutterstock.com
Dec 16, 2024, 13:09
Akhil Santhosh: FOWARC trial questions the role of RT in rectal cancer
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute and Post DM senior resident at AIIMS, New Delhi, posted the following on X:
“The 10-year results of FOWARC published in JCO ASCO today.
- No difference in DFS, LR, and OS between 5FU-RT, FOLFOX-RT, and FOLFOX alone for LA rectal cancer
- Second study after PROSPECT questioning the role of RT
- More LAR syndrome and persistent ostomy in CRT compared to chemo alone.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 1, 2025, 19:24
Aug 1, 2025, 19:14
Aug 1, 2025, 18:32